Cargando…
Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
BACKGROUND: Long-term maintenance of cognitive function is an important goal of treatment for Alzheimer’s disease (AD), but evidence about the long-term efficacy of cholinesterase inhibitors is sparse. To evaluate the long-term efficacy and safety of galantamine for AD in routine clinical practice,...
Autores principales: | Nakagawa, Ryoko, Ohnishi, Takashi, Kobayashi, Hisanori, Yamaoka, Toshio, Yajima, Tsutomu, Tanimura, Ai, Kato, Toshiya, Yoshizawa, Kazutake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402999/ https://www.ncbi.nlm.nih.gov/pubmed/28458553 http://dx.doi.org/10.2147/NDT.S133145 |
Ejemplares similares
-
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild‐to‐moderate Alzheimer's disease: a Bayesian network meta‐analysis
por: Kobayashi, Hisanori, et al.
Publicado: (2015) -
The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa, Ryoko, et al.
Publicado: (2015) -
The Prediction of Response to Galantamine Treatment in Patients with
Mild to Moderate Alzheimer’s Disease
por: Ohnishi, Takashi, et al.
Publicado: (2014) -
Estimation of minimal clinically important change of the Japanese version of EQ-5D in patients with chronic noncancer pain: a retrospective research using real-world data
por: Yoshizawa, Kazutake, et al.
Publicado: (2016) -
Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
por: Kim, Jae Kwang, et al.
Publicado: (2017)